Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

2026-11-18 14:02 •
The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.
Read More Here: https://www.cnbc.com/2026/11/18/hims-hers-peptides-plus-treatments.html